Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...
Healthcare product and device company Abbott Laboratories (NYSE:ABT) in Q4 CY2024, with sales up 7.2% year on year to $10.97 ...
His fears were that Abbott (NYSE:ABT) might pull the product entirely rather than risk further lawsuits—just like Johnson & ...
Two years later, Abbott held the speech at Noveon Magnetics in San Marcos. The business-friendly governor seems to have ...
The proclamation orders adds six technologies, including DeepSeek, Lemon8 and RedNote, to the state's prohibited technologies ...
Abbott (NYSE:ABT) is launching a new initiative that takes a look at some of the stigmas and stereotypes that come with ...
Material science firm R.D. Abbott has been serving the rubber industry since 1948. For its 75th anniversary in 2024, the ...
OpenAI creator Sam Altman claimed the AI model’s impact has been “wildly overstated” while Meta’s Mark Zuckerberg voiced confidence in his own company’s AI work. RedNote, also barred by Abbott in the ...
The governor touted Texas’ strong economy in his State of the State address Sunday, where he also laid out priorities he ...
The company's Q3 profit increased 16 per cent year-on-year (Y-o-Y) to Rs 360.78 crore as compared to Rs 310.98 crore ...
Shares of Abbott India surged 5.60% higher at ₹27,605.45 on the BSE on Tuesday. The pharma stock reacted positively to the ...
Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.2% year on year to $10.97 billion. Its non-GAAP profit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback